5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.72▲ | 8.66▲ | 8.66▲ | 8.93▼ | 7.97▲ |
MA10 | 8.67▲ | 8.69▲ | 8.69▲ | 8.70▲ | 7.39▲ |
MA20 | 8.69▲ | 8.79▼ | 8.83▼ | 7.98▲ | 7.42▲ |
MA50 | 8.88▼ | 8.97▼ | 8.77▲ | 7.21▲ | 8.92▼ |
MA100 | 9.02▼ | 8.52▲ | 8.10▲ | 7.37▲ | 16.36▼ |
MA200 | 8.65▲ | 7.78▲ | 7.63▲ | 8.82▼ | 103.99▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.025▲ | -0.003▼ | -0.032▼ | 0.068▲ | 0.386▲ |
RSI | 51.722▲ | 48.849▼ | 49.559▼ | 62.985▲ | 51.982▲ |
STOCH | 82.540▲ | 40.084 | 31.828 | 70.664 | 71.248 |
WILL %R | 0.000▲ | -7.692▲ | -52.000 | -34.743 | -18.439▲ |
CCI | 123.349▲ | 56.460 | -5.181 | 46.309 | 170.983▲ |
Tuesday, May 20, 2025 08:00 AM
Short interest in Atara Biotherapeutics Inc (NASDAQ:ATRA) decreased during the last reporting period, falling from 662.19K to 522.14K. This put 9.02% of the company's publicly available shares short.
|
Monday, May 05, 2025 02:06 PM
THOUSAND OAKS, Calif.--(BUSINESS WIRE)-- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...
|
Thursday, March 13, 2025 09:00 AM
Atara Biotherapeutics (ATRA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 8.57 | 8.855 | 8.50 | 8.82 | 34,168 |
12/06/25 | 8.88 | 8.88 | 8.56 | 8.71 | 43,134 |
11/06/25 | 9.1445 | 9.205 | 8.62 | 8.91 | 55,468 |
10/06/25 | 9.33 | 9.33 | 8.90 | 8.98 | 43,723 |
09/06/25 | 9.34 | 9.6825 | 9.0001 | 9.255 | 66,437 |
06/06/25 | 8.52 | 9.23 | 8.48 | 9.23 | 93,309 |
05/06/25 | 8.42 | 8.635 | 8.2301 | 8.42 | 38,620 |
04/06/25 | 8.48 | 8.55 | 8.205 | 8.33 | 61,936 |
03/06/25 | 7.90 | 8.42 | 7.7453 | 8.39 | 64,680 |
02/06/25 | 7.82 | 8.13 | 7.6262 | 8.00 | 93,691 |
|
|
||||
|
|
||||
|
|